WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004101590) NOVEL 14 AND 15 MEMBERED-RING COMPOUNDS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/101590    International Application No.:    PCT/EP2004/005086
Publication Date: 25.11.2004 International Filing Date: 11.05.2004
IPC:
A61K 31/7048 (2006.01), C07H 17/08 (2006.01)
Applicants: GLAXO GROUP LIMITED [GB/GB]; Glaxo Wellcome House, Berkeley Avenue, Greenford Middlesex UB6 0NN (GB) (For All Designated States Except US).
PLIVA - ISTRAZIVACKI INSTITUT D.O.O. [HR/HR]; Prilaz baruna Filipovica 29, 10000 Zagreb (HR) (For All Designated States Except US).
ALIHODZIC, Sulejman [HR/HR]; (HR) (For US Only).
BERDIK, Andrea [HR/HR]; (HR) (For US Only).
JARVEST, Richard, Lewis [GB/GB]; (GB) (For US Only).
LAZAREVSKI, Gorjana [HR/HR]; (HR) (For US Only)
Inventors: ALIHODZIC, Sulejman; (HR).
BERDIK, Andrea; (HR).
JARVEST, Richard, Lewis; (GB).
LAZAREVSKI, Gorjana; (HR)
Agent: GLADWIN, Amanda, Rachel; GlaxoSmithKline, Corporate Intellectual Property (CN925.1), 980 Great West Road, Brentford Middlesex TW8 9GS (GB)
Priority Data:
0310992.3 13.05.2003 GB
Title (EN) NOVEL 14 AND 15 MEMBERED-RING COMPOUNDS
(FR) NOUVEAUX COMPOSES A CYCLES A 14 ET 15 ELEMENTS
Abstract: front page image
(EN)The present invention relates to 15-membered macrolides substituted at the 4' position of formula (I) and pharmaceutically acceptable derivatives thereof, to processes for their preparation and their use in therapy or prophylaxis of systemic or topical microbial infections in a human or animal body.
(FR)La présente invention se rapporte à des macrolides à 15 éléments substitués en position 4'' de formule (I) et à leurs dérivés pharmaceutiques acceptables, à leurs procédés de préparation et à leur utilisation dans le traitement ou la prophylaxie d'infections microbiennes systémiques ou topiques dans le corps d'un humain ou d'un animal.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)